v3.25.2
CO-DEVELOPMENT RIGHTS (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2021
Jun. 30, 2025
Dec. 31, 2024
Co Development Rights [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Capitalized contract costs     $ 5,291,667  
Capitalized contract costs, accumulated amortization     4,237,500  
Capitalized contract costs, net     $ 1,054,167  
CD38 Assets [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Other Notes Payable, Noncurrent   $ 1,750,000    
Purple Bio Tech [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Convertible notes outstanding       $ 218,750
Repayment of convertible debt $ 218,750      
Vy-Gen [Member] | CD38 Assets [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Payments to Acquire Productive Assets   1,750,000    
Other Notes Payable, Noncurrent   3,250,000    
Repayments of Long-Term Debt   1,500,000    
Capitalized contract costs   $ 5,000,000